UC Provides Free Breast and Cervical Screening
Ohio women aged 40 and over with limited income or insufficient health insurance could be eligible for free breast and cervical cancer screening, thanks to the UC Breast and Cervical Cancer Project (BCCP).
The project, intended to improve a patient's chances of recovery through early diagnosis, is funded by the Centers for Disease Control and Prevention (CDC) and the Ohio Department of Health BCCP Medicaid program. It is administered in southwestern Ohio by UC's Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Participants will receive a free Pap test, pelvic exam, clinical breast exam, mammogram and follow-up diagnostic procedures at any of 60 contracted sites throughout southwestern Ohio. For more details and to determine eligibility call 513-584-4342, 513-584-0053 or (toll free) 1-888-727-6266, from 8 a.m. to 5 p.m. Monday through Friday.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.